Imaging's ride to the bottom in clinical trials—and why it matters now - The Cancer Letter
Tumor response criteria like RECIST are human-readable standards defined by regulators. An AI model that calculates response would need to itself be a ...
Read the original at The Cancer Letter ↗
- Topics
- HealthcareRegulation & Policy
- Tracked via
- “An AI Model that”